Model Introduction
Migraine is a chronic disabling neurological disorder characterized by periodic episodes of moderate-to-severe throbbing headache. Our center provides mature models built on various core hypotheses, covering the entire pathological process from electrophysiological abnormalities to vasomotor dysfunction:
- Cortical Spreading Depression (CSD) Model: Simulates the pathogenesis of migraine aura.
- Vasogenic Model (Nitroglycerin-induced): Uses NO donors to induce extra- and intracranial vasodilation and nociceptor activation.
- Trigeminovascular System Model: Simulates the transmission of pain information via electrical stimulation of the dura mater or trigeminal ganglion.
- Genetically Engineered Mouse Models: Targets ion channel gene mutations related to Familial Hemiplegic Migraine (FHM).
Research Applications
- Pathogenesis Exploration: Studying cortical electrical activity, trigeminal system activation, and neuropeptide release mechanisms.
- Drug Screening and Evaluation: Assessing the efficacy of analgesics, vasoconstrictors, and CGRP receptor antagonists.
- Preventive Treatment Research: Targeted at long-term intervention experiments for chronic migraine.
Key Points of Experimental Design
- Animal Selection: CSD models prefer adult SD rats (>2 months old, weight >300g); Nitroglycerin models can use rats or mice.
- Modeling Keys:
- CSD Method: Requires precise stereotaxic localization based on Bregma coordinates; prevent brain tissue damage during drilling; maintain electrical stimulation parameters (e.g., 1mA, 300ms).
- Nitroglycerin Method: Choose subcutaneous or intraperitoneal injection based on acute/chronic needs; control dosage to maintain symptom stability.
- Electrical Stimulation: Requires a stereotaxic apparatus and dental cement to fix electrodes; ensure constant stimulation frequency (20Hz) and intensity (2.5-3.5mA).
Key Monitoring Indicators
- Behavioral Indicators: Frequent head scratching, ear redness, piloerection, increased cage climbing, and decreased periorbital mechanical pain threshold.
- Electrophysiological Indicators: Cortical steady potential, electrocorticogram (recording CSD duration, amplitude, and frequency).
- Biochemical Indicators: Determination of CGRP (Calcitonin Gene-Related Peptide) and Substance P levels in plasma.


